
Photo taken from Erman Akkus/X
Jul 1, 2024, 02:54
Erman Akkus: Take home messages from Proffered Papers session at ESMOGI24
Erman Akkus, Medical Oncology Fellow at Ankara University, shared a post on X:
“Take home messages from Proffered Papers session.
- Liver transplantation and ChT prolong PFS, OS and safe with no QoL harm, in very selected LMCRC (TRANSMET)
- 1L nivo-ipi in dMMR mCRC prolongs PFS with better QoL (Checkmate 8HW)
- First trifuluridine/tripacil then regorafenib is better than rego-trif sequence in beyond 2L treatment of mCRC (SOREGATT)
- Adding pembro to periopereative therapy of locally advanced GEJ improves pCR rate (KEYNOTE-585)
- Switching paclitaxel-ramicurumab after disease control by 5FU-ox prolongs PFS and OS (ARMANI).”
Source: Erman Akkus/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 21, 2025, 15:06
Feb 21, 2025, 14:27
Feb 21, 2025, 14:13
Feb 21, 2025, 13:29